A diagnostic challenge after neoadjuvant chemoimmunotherapy: looking beyond tumor recurrence
Content available only in Spanish.
Between evidence and fear of recurrence: decision-making in adjuvant treatment of a ypT1aN0 case after neoadjuvant therapy. Are we ready to forgot treatment?
Content available only in Spanish.
Synchronous small-cell lung cancer and metastatic gastric gastrointestinal stromal tumor: concurrent chemo-radiotherapy, consolidation immunotherapy, and imatinib
Introduction Lung cancer is the most incident tumor in the world, with approximately 2.480.675 new cases annually and it is also the leading cause of cancer mortality, accounting for 1.817.469 deaths per year according to GLOBOCAN data.1 Data from the Spanish Group of Lung Cancer (GECP) Lung Cancer Observatory indicate that small-cell lung cancer (SCLC) […]
Lambert-Eaton syndrome associated with small cell lung cancer
Content available only in Spanish.
Reactivation of an anti-Hu paraneoplastic syndrome in a patient with small-cell lung cancer treated with immunotherapy: a diagnostic and therapeutic challenge
Content available only in Spanish.
The use of immune checkpoint inhibitors in the treatment of advanced non-small cell lung cancer in a bilateral lung transplant recipient
Content available only in Spanish.
Prolonged response to osimertinib in EGFR exon 20 insertion and SETD2 loss-of-function mutation in advanced NSCLC: a molecular paradox
Content available only in Spanish.
Tako-Tsubo syndrome after alectinib initiation
Introduction Anaplastic lymphoma kinase (ALK) inhibitors have revolutionized the treatment of ALK-positive non-small cell lung cancer (NSCLC), significantly improving survival and quality of life. Among second-generation ALK inhibitors, alectinib has been widely used due to its superior efficacy and safety profile compared to first-generation agents like crizotinib, as demonstrated in the phase III ALEX trial1 […]
Long-term survivor with advanced small-cell lung carcinoma: the role of maintenance immunotherapy and local treatment of oligoprogression
Content available only in Spanish.
Clinical-radiological discordance after neoadjuvant chemoimmunotherapy in resectable lung squamous cell carcinoma
Content available only in Spanish.